SON BK,BONG JG,PARK SH,et al.Ductal carcinoma in situ and sentinel lymph node biopsy.J Breast Cancer,2011,14:301-307. TRENTIN C,DOMINELLI V,MAISONNEUVE P,et al.Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy:experience of 733 cases.Breast,2012,21(5):635-640.ĭOYLE B,AL-MUDHAFFER M,KENNEDY MM,et al.Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ:is it justified?.Clin Pathol,2009,62(6):534-538. INTRA M,ROTMENSZ N,VERONESI P,et al.Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast:the experience of the European Institute of Oncology on 854 patients in 10 years.Ann Surg,2008,247(2):315-319. SAKR R,BEZU C,RAOUST I,et al.The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ:risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes.Int J Clin Pract,2008,62(11):1730-1735. KILLELEA BK,LONG JB,DANG W,et al.Associations between sentinel lymph node biopsy and complications for patients with ductal carcinoma in situ.Ann Surg Oncol,2018,25(6):1521-1529.ĬHIN-LENN L,MACK LA,TEMPLE W,et al.Predictors of treatment with mastectomy.Use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.Ann Surg Oncol,2014,21:66-73. LANGER I,GULLER U,BERCLAZ G,et al.Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery:a prospective Swiss multicenter study on 659 patients.Ann Surg,2007,245(3):452-461. MANSEL RE,FALLOWFIELD L,KISSIN M,et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer:the ALMANAC Trial.J Natl Cancer Inst,2006,98(9):599-609. PURUSHOTHAM AD,UPPONI S,KLEVESATH MB,et al.Morbidity after sentinel lymph node biopsy in primary breast cancer:results from a randomized controlled trial.J Clin Oncol,2005,23(19):4312-4321.īIANCO PDEL,ZAVAGNO G,BURELLI P,et al.Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients:results of the sentinella-GIVOM Italian randomised clinical trial.Eur J Surg Oncol,2008,34(5):508-513. MARQUES LC,MARTA GN,DE ANDRADE JZ,et al.Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes,using a simple score!.Eur J Surg Oncol,2019,45(7):1152-1155.īRENNAN ME,TURNER RM,CIATTO S,et al.Ductal carcinoma in situ at core-needle biopsy:meta-analysis of underestimation and predictors of invasive breast cancer.Radiology,2011,260:119-128. NICE GUIDELINE.Early and locally advanced breast cancer:diagnosis and treatment. Sentinel lymph node biopsy for patients with early-stage breast cancer:2016 American Society of Clinical Oncology clinical practice guideline update summary.J Oncol Pract,2017,13(3):196-198. Conclusions The risk of clinically significant SLN metastasis following a CNB diagnosed DCIS is extremely low SLNB is not warranted following a CNB diagnosed DCIS,particularly for patients undergoing 8-gauge vacuum assisted breast biopsy or breast conservation surgery.ĭuctal carcinoma in situ (DCIS) sentinel lymph node core needle biopsy (CNB) Compared with the pure DCIS group,the proportion of tumor >2 cm ( P<0.001),extensive calcification ( P<0.001),14/16 g needle biopsy ( P<0.001) and mastectomy ( P=0.03) in the micro-invasive/invasive carcinoma group were higher than that in the pure DCIS group.SLNB was positive in 7 (4.1%) patients,all were diagnosed with 14/16 g needle biopsy.The results of SLNB were negative in 8 g vacuum assisted biopsy system and breast conserving surgery patients. Breast conserving surgery was performed in 29 cases (17.2%),and mastectomy in 140 cases (82.8%).Ninety-three cases (55%) were diagnosed by 14/16 g needle biopsy,76 cases (45%) were diagnosed by 8 g vacuum assisted biopsy system. Results Of 169 patients with a CNB diagnosed DCIS,all had SLNB,among which 117(69.2%) were pure DICS,28 (16.6%) were DICS with microinvasion,and 24(14.2%) were invasive ductal carcinoma. Methods The cases of CNB diagnosed DCIS treated in our hospital between Jan.2010 to Dec.2018 were included.The results of SLNB were analyzed. Abstract Objective To analysis the sentinel lymph node biopsy (SLNB)results of core needle biopsy (CNB) diagnosis of breast ductal carcinoma in situ (DCIS) and to understand the clinical significance of SLNB in DCIS.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |